PREVENAR (Pfizer Australia Pty Ltd)
Product name
PREVENAR
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
188 (255 working days)
Active ingredients
Pneumococcal purified capsular polysaccharides
Registration type
EOI
Indication
Active immunisation for the prevention of pneumococcal disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, and 33F in individuals from 6 weeks of age and older.
PREVENAR 20 may not prevent disease caused by S. pneumoniae serotypes that are not contained in the vaccine.
PREVENAR 20 should be used in accordance with official recommendations.
This webpage on the TGA website was printed on 10 Sep 2024. Printed content may be out of date. For up-to-date information, always refer to the digital version: https://www.tga.gov.au/resources/prescription-medicines-registrations/prevenar-pfizer-australia-pty-ltd